Un ¡verza v Mariboru
Medicinska fakulteta
Impressum
ACTA MEDICO-BIOTECHNICA
Ustanovitelj / Founder_
Medicinska fakulteta Univerze v Mariboru Faculty of Medicine University of Maribor
Izdajatelj / Publisher_
Medicinska fakulteta Univerze v Mariboru Faculty of Medicine University of Maribor Izid publikacije je finančno podprla ARRS iz sredstev državnega proračuna iz naslova razpisa za sofinanciranje domačih znanstvenih periodičnih publikacij.
Izdajateljski svet / Publishing Council_
Vojko Flis Radovan Hojs Željko Knez Ivan Krajnc Dušica Pahor Igor Tičar Matjaž Vogrin
Odgovorna urednica / Editor-in-Chief
Dušica Pahor
Uredniki / Co-editors_
Darja Arko Vojko Flis Radovan Hojs Željko Knez Ivan Krajnc Andraž Stožer
Pridruženi uredniki / Associate Editors
Wilfred Druml, Wien, Austria
Sinikka Eskelinen, Oulu, Finland
Thomas Gamse, Graz, Austria
Raul J. Gazmuri, North Chicago, USA
Dan Gilon, Jerusalem, Israel
Christoph H. Gleiter, Tübingen, Germany
Winfried Graninger, Wien, Austria
Hervig Holzer, Graz, Austria
Franz M. Kainberger, Wien, Austria
Joachim R. Kalden, Erlangen, Germany
Günter J. Krejs, Graz, Austria
Boris Labar, Zagreb, Croatia
Gerhard K. Lang, Ulm, Germany
Rifat Latifii, Valhalla, New York
Sigurd Lax, Graz, Austria
Henrik Mulec, Trollhättan, Sweden
Péter Németh, Pécs, Hungary
Yoram Oron, Tel Aviv, Israel
Norbert Roewer, Würzburg, Germany
Heikki Ruskoaho, Oulu, Finland
Josef S. Smolen, Wien, Austria
Markku Savolainen, Oulu, Finland
Manfred Schattenkirchner, München, Germany
Felix Unger, Salzburg, Austria
Durda Vasic-Racki, Zagreb, Croatia
Razširjeni uredniški odbor - Znanstveni svetovalci / Expanded Editorial Board - Scientific Advisory Board
Sebastijan Bevc, Gorazd Bunc, Igor But, Anton Crnjac, Bogdan Cižmarevič, Andrej Cretnik, Robert Ekart, Ivan Eržen, Aleš Holobar, Tanja Hojs Fabjan, Breda Jesenšek Papež, Mirt Kamenik, Zalika Klemene Ketiš, Nadja Kokalj Vokač, Miljenko Križmaric, Blanka Kores Plesničar, Metoda Lipnik Štangelj, Marko Marhl, Uroš Maver, Dušan Mekiš, Dušanka Mičetič Turk, Kazimir Miksič, Artur Pahor, Breda Pečovnik Balon, Božena Pejkovič, Uroš Potočnik, Stojan Potrč, Petra Povalej Bržan, Milan Reljič, Maja Rupnik, Andreja Sinkovič, Pavel Skok, Andraž Stožer, Tadej Strojnik, Karin Stana Klainschek, Tomaž Šeruga, Draga Štiblar Martinčič, Iztok Takač, Ksenija Tušek Bunc
Tehnični urednik / Technical editor_
Prof. dr. Uroš Maver, mag. farm.
Izhajanje revije / Publishing_
Revija izhaja dvakrat letno. Ta številka je izšla v nakladi 500 izvodov. Članki so dostopni tudi na svetovnem spletu. The journal is published twice a year. Manuscripts are available on the journal's home page.
Revija Acta medico-biotechnica (AMB) je indeksirana v naslednjih bazah: COBISS, DLib.si, Ulrich's Periodical Directory.
The Journal Acta medico biotechnica (AMB) is indexed and abstracted in the following databases: COBISS, DLib.si, Ulrich's Periodical Directory.
Lektoriranje / Language Editing
Katja Meško Peserl, prof. slov. International Science Editing, Ireland
Oblikovanje / Design_
Tabula, Tadej Kajzer s.p.
Slika na naslovnici / Cover illustration
(stran 33 /page 33)
ISSN tiskana izdaja: 1855-5640 ISSN elektronska izdaja: 1855-7988 ISSN Print Edition: 1855-5640 ISSN E-Edition: 1855-7988
acta medico-biotechnica
2019; 12 (2): 1
Splošne informacije
SPLOSNE INFORMACIJE
ISSN tiskana izdaja: 1855-5640 ISSN elektronska izdaja: 1855-7988
Intemetna stran:
www.actamedbio.mf.um.si
Splošno o reviji
Acta medico-biotechnica
Acta medico-biotechnica je uradna znanstvenoraziskovalna strokovna revija Medicinske fakultete Univerze v Mariboru, ki je namenjena širšemu krogu bralcev, saj pokriva področje medicine in biotehnike. Revija bo izhajala najmanj dvakrat letno, v njej objavljene prispevke pa bo strokovno recenziral mednarodni uredniški odbor.
Pogoji
Uredniški odbor ima pravico odločiti, ali je prispevek sprejet v objavo, določiti recenzente preko mednarodnega uredniškega odbora in, če je potrebno, zahtevati spremembe v vsebini, dolžini ali jeziku.
V spremnem dopisu vsakega prispevka morajo biti navedeni naslednji podatki o avtorju, ki je pristojen za dopisovanje:
ime, naslov, e-naslov, telefonska številka in številka telefaksa. Obvezna vsebina dopisa je izjava, v kateri se avtor in morebitni soavtorji strinjajo z objavo, navesti je potrebno, da prispevek ni bil predhodno objavljen in da ni v pripravi za objavo v kateri koli drugi publikaciji. Glavni urednik si pridržuje vso pravico, da prispevek zavrne, če le-ta ni v skladu z zgoraj navedenimi zahtevami.
Avtorske pravice
Ko je prispevek sprejet v objavo, se avtorske pravice prenesejo na uredništvo, to je v trajno last revije. Revija si avtorske pravice pridržuje, kar pomeni, da ima izključno pravico do ponovne objave, distribucije članka, prav tako pa tudi pravico do prevoda v drug jezik. Brez predhodnega pisnega dovoljenja uredništva ni mogoče uporabljati podatkov, ki so bili objavljeni v reviji.
Zakonske zahteve
Prispevek, ki je namenjen objavi, mora vsebovati izjavo, da je vse raziskave, izvedene na ljudeh, pregledala Etična komisija in so v skladu z etičnimi standardi, ki jih predpisuje Helsinška deklaracija (l. 1964). Razvidno mora biti, da so preiskovanci dali pisno soglasje k sodelovanju pri raziskavi.
Odgovornost
Vsi zaključki, mnenja in podatki, objavljeni v prispevku, so izključno delo avtorja in ne izdajatelja ali uredništva. Izdajatelj in uredniki ne sprejmejo nobene kazenske odgovornosti za kakršne koli napake, ki bi bile tako storjene.
NAVODILA ZA AVTORJE
Pošiljanje prispevka
Za čim učinkovitejšo in hitro vodenje postopka se vsi prispevki posredujejo uredništvu revije po elektronski pošti na naslov actamedbio@um.si. Navodila avtorjem so na voljo na spletni strani revije:
www.actamedbio.mf.um.si V primeru težav pri pošiljanju lahko pokličete uredništvo na tel. št. +386 2 2345 827 (Tehnični urednik izr. prof. dr. Uroš Maver, mag. farm.).
Vrste objavljenih prispevkov
Uvodnik: do 1000 besed, izvleček ni potreben, največ pet referenc, le na povabilo urednika.
Pregledni članek: do 2000 besed, ne-strukturiran izvleček z do 250 besedami, največ 50 referenc, le na povabilo urednika.
Klinična študija: do 3500 besed, strukturiran izvleček z največ 250 besedami, maksimalno 50 referenc. Laboratorijska študija: do 3500 besed, strukturiran izvleček z največ 250 besedami, maksimalno 50 referenc. Poročilo o primeru: 750 besed, strukturiran izvleček (Namen, Poročilo o primeru, Zaključek) z največ 200 besedami, maksimalno 12 referenc.
PRIPRAVA PRISPEVKA
Prispevek mora biti napisan v angleškem jeziku, z izvlečkom v sloven-
UREDNIŠTVO »ACTA MEDICO-BIOTECHNICA«
Prof. dr. D. Pahor, dr. med. Odgovorna urednica Univerza v Mariboru Medicinska fakulteta Taborska ul. 8 SI-2000 Maribor, Slovenija Tel. +386 22345827 Faks +386 22345820
Spletna stran: http://www.actamedbio.mf.uni-mb.si/sl
acta medico-biotechnica
2019; 12 (2): 2-3
Splošne informacije
skem in angleškem jeziku, na papirju velikosti A4 (210 x 297 mm) s 3 centimetrskimi stranskimi robovi in dvojnim presledkom med vrsticami. Strani prispevka morajo biti oštevilčene. Priporočena dolžina je 15 tipkanih strani (6 tiskanih strani). Članek mora biti shranjen v svoji originalni obliki (Microsoft Word for Windows), ves slikovni material pa v posebni datoteki. Tekst mora biti jasno razdeljen na naslednja poglavja:
Izvleček, Uvod, Material in metode, Rezultati in Razprava.
Naslovna stran
Vsebovati mora:
•	natančen in jasen naslov,
•	ime in priimek avtorjev,
•	ime in naslov ustanov avtorjev,
•	naslov za dopisovanje pristojnega avtorja (e-mail naslov, telefon in številka faksa).
Druga stran
•	Izvle~ek: strukturiran izvleček mora vsebovati osnovne značilnosti prispevka v logičnem in jasnem zaporedju. Podati mora naslednje informacije: namen, metode, rezultate in zaključek. Izvleček ne sme presegati 250 besed.
•	Klju~ne besede: največ 3-6 besed, pomembnih za indeksiranje.
Tekst
Tekst naj bo razdeljen na naslednja poglavja: Uvod, Material in metode (vključno z izjavo Etične komisije, kjer je to potrebno), Rezultati, Razprava z zaključki, Zahvala in Literatura.
•	Uvod: v uvodu je potrebno navesti namen raziskave in posredovati kratek pregled literature zaradi boljšega razumevanja in ocenjevanja dobljenih rezultatov.
•	Material in metode: v tem delu morajo biti natančno opisani vsi eksperimentalni postopki, tako da jih lahko ostali ponovijo. Avtor mora navesti ime proizvajalca za vso opremo in inštrumente. Zdravila je potrebno imenovati s farmacevtskimi nazivi.
•	Če gre v prispevku za poskus na živalih ali prostovoljcih, je potrebno na koncu poglavja Material in metode vključiti izjavo »Potrjujem-o, da je bila raziskava opravljena v skladu z etičnimi načeli in zakonodajo.«
•	Rezultati: v rezultatih je potrebno jasno in natančno prikazati v raziskavi dobljene rezultate v tekstu in v obliki tabel in slik.
•	Razprava: razpravljanje naj bo usmerjeno v razlago in pomen dobljenih rezultatov z jasnimi objektivnimi pripombami, vključno s primerjavo dobljenih rezultatov podobnih raziskav s tega področja. Razpravi sledi zaključek.
•	Zahvala: zahvala naj vključuje vse sodelujoče, ki so prispevali k raziskavi, vendar niso omenjeni kot avtorji, in naj bo čim krajša.
•	Literatura: literaturo je potrebno citirati po vrstnem redu, kot se prvič pojavlja v tekstu, in sicer z arabskimi številkami (Vancuver style). Navedena naj bodo samo že objavljena dela (in sprejeti prispevki za objavo), pri čemer se navedeta prva in zadnja stran. V primeru, ko je avtorjev več kot šest, navedite imena prvih šestih in dodajte et al. Priimkom avtorjev je potrebno dodati še začetno črko imena. Imena revij krajšajte kot to določa Index Medicus.
•	Enote in okraj{ave: SI enote in okrajšave se navajajo s polnim imenom ob prvi navedbi v tekstu.
•	Slikovno gradivo: ilustracije, diagrami in fotografije morajo biti označeni s številko, in sicer v zaporedju, v katerem se pojavljajo v tekstu. Legende ilustracij in diagramov naj bodo kratke, vendar z zadostnimi podatki, napisanimi na koncu prispevka na posebnem listu. Crno-bele in barvne fotografije morajo imeti resolucijo od 300 dpi, linijske risbe od 800 do 1.200 dpi. Poslane morajo biti v posebni elektronski datoteki. Objava šestih ali manj barvnih fotografij/ ilustracij je brezplačna.
•	Tabele: ob tabelah se morajo navesti legenda, naslov in pojasnilo vseh uporabljenih okrajšav. Vsaka tabela se mora nahajati na posebni strani, biti mora oštevilčena, naslovljena in citirana v tekstu. Tabele so lahko oblikovane v Wordu ali podane v posebni elektronski datoteki.
Krtačni odtis
Korekcija članka bo poslana v PDF datoteki po e-pošti avtorju, ki je pristojen za dopisovanje. Avtor mora označiti napake, preveriti, ali je besedilo popolno in ali so vključene vse fotografije in tabele. Krtačni odtis je potrebno čim prej vrniti uredništvu. Spremembe v odtisu z izjemo tiskarskih napak niso možne, razen s posebnim dovoljenjem odgovornega urednika.
Uredništvo ne odgovarja za škodo ali izgubo poslanih prispevkov. Avtorjem predlagamo, da obdržijo kopije svojih prispevkov in slikovnega gradiva.
acta medico-biotechnica
2019; 12 (2): 3-3
General information
GENERAL INFORMATION
ISSN Print Edition: 1855-5640 ISSN E-Edition: 1855-7988
Journal Homepage:
www.actamedbio.mf.um.si
Publication data
Acta medico-biotechnica is the official journal of the Faculty of Medicine, University of Maribor in Slovenia. This scientific-professional journal contains material of interest to a wider readership covering the medical and biotechnical fields.
The journal is published twice a year. Papers are peer reviewed by an international Editorial Board.
Conditions
The Editorial Committee of »Acta medico-biotechnica« reserves the right to decide whether a paper is acceptable for publication, to obtain peer reviews by an international Editorial Board for submitted papers, and if necessary, to require changes in the content, length or language. A cover letter with the name, address, telephone and telefax numbers of the corresponding authors must accompany each manuscript. This letter must include a statement that affirms that publication has been approved by all co-authors, that the work has not
been published previously and that is not under consideration by another publication. The Editor-in-Chief reserves the right to reject manuscripts that do not comply with the above mentioned requirements.
Copyright
Submission of an article for publication implies transfer of the copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of »Acta medico-biotechnica«. All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article as well as all translation rights. No material published in this journal may be reproduced without first obtaining written permission from the publisher.
Legal requirements
Manuscripts submitted for publication must contain a statement that all human studies have been reviewed by the appropriate ethics committee in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. It must be clear that all persons gave informed consent before their inclusion in the study.
Disclaimei
The statements, opinions and data contained in this publication are solely those of the individual authors and not of the publisher and the Editors.
Neither the publisher nor the Editors can accept any legal responsibility for any errors that may be made.
INSTRUCTIONS FOR AUTHORS
Submission of Manuscript
All manuscripts must be submitted in English by e-mail to the editorial office at actamedbio@um.si to achieve quick and efficient processing. Instructions for Authors will be available online at www.actamedbio.mf.um.si Should you experience any problems with your submission, please contact the Editorial Office at tel. no. +386 (0) 2 2345 827 (Technical editor Associate professor Uros Maver, B. Sc.).
Types of Papers
The types of accepted manuscripts are: Editorial: 1000 words maximum, no abstract required, maximum 5 references, only by invitation of the Editor Review: 2000 words maximum, unstructured abstract of 250 words maximum, maximum 50 references, only by invitation of the Editor Clinical study: 3500 words maximum, structured abstract of 250 words maximum, maximum 50 references Laboratory study: 3500 words maximum, structured abstract of 250 words maximum, maximum 50 references Case report: 750 words, structured abstract (Purpose, Case Report, Conclusion) of 200 words maximum, maximum 12 references
PREPARATION OF MANUSCRIPT
Manuscripts must be typed in English and double-spaced on A4-sized pages (210 x 297 mm) with a margin of at least 3 cm. All manuscript pages must be numbered. The recommended length is 15 manuscript pages (6 printed pages). The article must be
EDITORIAL OFFICE »ACTA MEDICO-BIOTECHNICA«
Prof. D. Pahor, MD, PhD Editor-in-chief University of Maribor Faculty of Medicine Taborska ul. 8 SI-2000 Maribor, Slovenia Tel. +386 22345827 Fax +386 22345820
Journal home page: www.actamedbio.mf.um.si
3 acta medico-biotechnica
2019; 12 (2): 4-5
General information
saved in its original application (Microsoft Word for Windows) and all figures must be saved as separated files from the text. Manuscripts should be divided clearly into Abstract, Purpose, Methods, Results, Discussion, Acknowledgements (if any), References and Figure legends.
Title Page
•	A concise and informative title
•	Full name of each author
•	Affiliation and address of each author
•	E-mail address, telephone and fax numbers of the corresponding author
Second page
•	Abstract: Structured abstract must summarise the essential features of the paper in logical and concise sequences. It should contain the following headings: Purpose, Methods, Results, Conclusion and should not exceed 250 words.
•	Key words: A list of 3-6 key words is essential for indexing purposes.
Text
Please use the following headlines: Introduction, Material and methods (including Statement of Ethics where applicable), Results, Discussion with Conclusions at the end, Acknowledgements (if any), References.
•	Introduction: The Introduction should state the purpose of the investigation and give a short review of the pertinent literature to allow the results of the paper to be understood and evaluated.
•	Material and methods: This section should contain sufficient detail so that all experimental procedures can be repeated by others. Authors should provide the name of the manufacturer for any specifically named equipment and instruments. All drugs should be identified by their pharmaceutical names.
Where the manuscript concerns animal experimentation or the use of human volunteers, the authors should include a statement at the end of the Material and methods: »We/I certify that all applicable institutional and governmental regulations concerning the ethical use of human volunteers/animals were followed during this research.«
•	Results: The results should clearly and concisely present the outcome of the study and include tables or figures if required.
•	Discussion: The discussion should focus on the interpretation and significance of the findings with concise objective comments that describe their relationship to other previously published work in the area. At the end of discussion, one or more conclusions that have been drawn from the results and subsequent discussion should be present.
•	Acknowledgements: A note of acknowledgements is appropriate for all other contributors who are not listed as authors. These should be as brief as possible.
•	References: References should be listed in order of appearance (Vancouver style) by Arabic numerals. Only published works (as well as manuscripts that are already accepted for publication) should be listed in the reference list with first and last page numbers. References with fewer than 6 authors should list all authors. For more than 6 authors, list the first six names followed by et al. The surnames of the authors followed by initials should be given. Abbreviate journal names according to the Index Medicus.
•	Units and abbreviations: SI units must be used and abbreviations must be given in full at the first mention in the text.
•	Figures: Figures and images should be labelled sequentially, numbered and cited in the text. Figures legends should be brief with sufficient explanations of the illustrations and placed on a separate page at the end of the text. Black and white halftone and colour illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 8001,200 dpi. Figures should be sent in separate electronic files. There is no extra charge for up to 6 colour figures or illustrations.
•	Tables: Tables should have a legend that includes the title of the table and an explanation of any abbreviations used in that table. Each table should be placed on a separate page, numbered and titled and cited in the text. Unlike figures or images, tables may be embedded in the manuscript file if necessary, or supplied as separate electronic files.
Proofreading
The proof will be sent by e-mail to the corresponding author. Authors should make their proof corrections on a printout of the pdf file supplied, checking that the text is complete and that all figures and tables are included. Proofs must be returned to the publisher with the least possible delay. Alterations made in proofs, other than the correction of printer's errors are not allowed without approval of the responsible Editor. In such a case, please contact the Editorial office before returning the proofs to the publisher. The Editors cannot accept responsibility for damage to or loss of manuscripts submitted to them. Contributors are advised to keep copies of their manuscript and illustrations.
3 acta medico-biotechnica
2019; 12 (2): 5-5
Kazalo / Contents
ACTA MEDICO-BIOTECHNICA
KAZALO / CONTENTS
8 - 9
Etična odgovornost pri objavljanju znanstvene publikacije urednikov revij in avtorjev Ethical responsibility of journal editors and authors when publishing scientific publications
Dušica Pahor
10 - 20
Sodoben pristop k diagnostiki žensk s sumom na pelvično endometriozo
Contemporary approach to diagnostics in women with suspected pelvic endometriosis
Jure Knez, Andraž Dovnik, Maja Pakiž, Igor But, Milan Reljič, Vida Gavrič Lovrec, Maja Banovič, Iztok Takač
21 - 28
Zgodnje odkrivanje metastaz v bezgavkah v vratu pri bolnicah z rakom dojke: vloga ultrazvoka in igelne biopsije
Early detection of neck lymph node metastases in breast cancer patients: the role of ultrasound and fine needle biopsy
Janez Rebol, Peter Balon, Peter Kokol, Boštjan Lanišnik, Iztok Takač, Andraž Dovnik, Nina Fokter Dovnik, Monika Sobočan, Darja Arko
29 - 38
Predoperativna ledvična disfunkcija je napovedni
dejavnik pooperativne atrijske fibrilacije pri bolnikih po
kirurški revaskularizaciji srca
Preoperative renal dysfunction is a predictor of
postoperative atrial fibrillation in coronary artery bypass
patients
Miha Antonič
39 - 48
Ultrazvočna ocena okvare levega prekata z doplersko ehokardiografijo in izračunom indeksa okvare levega prekata (iLVI) pri bolnikih s kroničnim srčnim popuščanjem
Assessment of left ventricular impairment by calculating left ventricular impairment index using doppler echocardiography in chronic heart failure patients
Igor Krajnc, Andreja Sinkovič
49 - 58
Kumulativna stopnja zanositve in živorojenih otrok pri
intrauterini inseminaciji in in vitro fertilizaciji pri parih z
nepojasnjeno neplodnostjo
Cumulative pregnancy and live birth rates following
intrauterine insemination and in vitro fertilization in
couples with unexplained infertility
Nejc Kozar, Borut Kovačič, Milan Reljič, Vilma Kovač
59 - 68
Vpliv kombiniranega nadaljevalnega zdravljenja na simptomatiko in kvaliteto življenja otrok s hiperkinetično motnjo: prospektivna opazovalna študija Impact of Combined Continuous Treatment on the Symptoms and Quality of Life of Children with Attention Deficit Hyperactivity Disorder: A Prospective Observational Study
Saška Venek, Hojka Gregorič Kumperščak
acta medico-biotechnica §7_
2019; 12 (2): 6-6
Kazalo / Contents
69 - 80
Razmerje subendokardne viabilnosti, ambulantno merjenje krvnega tlaka in serumski označevalci srčno-žilnih bolezni pri bolnikih s kronično ledvično boleznijo Subendocardial viability ratio, ambulatory blood pressure monitoring and serum biomarkers for cardiovascular disease in chronic kidney patients Nejc Piko, Tajda Šrot, Nina Hojs, Sebastjan Bevc, Radovan Hojs, Robert Ekart
81 - 88
Učinki gabapentina in etanola na regulirano celično smrt astrocitov v primarni kulturi The effects of gabapentin and ethanol on the regulated cell death of astrocytes in primary culture
Paulina Hutyrova, Jan Stangelj, Metoda Lipnik-Stangelj
acta medico-biotechnica §7_
2019; 12 (2): 6-7
Uvodnik / Editorial
Etična odgovornost pri objavljanju znanstvene publikacije urednikov revij in avtorjev
Etika je bila in vedno bo najpomembnejši del znan-stveno-raziskovalnega dela. V zgodovini je bila pogosto zlorabljena, vendar moramo na podlagi izkušenj skrbeti za to, da se zgodovina ne ponavlja. Etika mora biti prisotna na vseh področjih raziskovanja. Kakršna koli želja po uspehu, slavi ali drugih osebnih koristih mora vedno biti pod strogo kontrolo, ki preprečuje možnost zlorabe znanosti. To je tudi želja in poslanstvo uredništva.
Zakaj v uvodniku obravnavam to tematiko? Ker se nam je to skoraj zgodilo. V naši reviji smo skoraj objavili že objavljen članek, za katerega so avtorji izjavili nasprotno. Po desetih letih izdajanja revije preprosto nismo verjeli v zlorabo, saj verjamemo v človeško poštenost. In to je naša napaka. Uredništvo ne more več temeljiti na zaupanju, potreben je nadzor in hkrati uvedba sankcij za avtorje, ki skušajo objaviti že objavljene prispevke. Da smo preprečili zlorabo, se moramo zahvaliti izključno odlični recenzentki, ki je opisano ugotovila in nas na to opozorila. Ponovno ugotavljam, da sta delo recenzenta in njegova potrditev izvirnosti izjemnega pomena, zlasti kadar gre za področje medicine, najbolj občutljivega področja glede etike na področju raziskovanja. Večina revij od pošiljatelja prispevka zahteva izjavo, ki potrjuje izvirnost prispevka in dejstvo, da ta ni bil poslan v objavo v druge znanstvene revije. Tudi naša revija. Da do zlorabe ne pride, je pomembno, da avtor počaka na odgovor prve revije, preden pošlje prispevek v drugo revijo. Neučakanost, še posebej pogojena s strani lastne koristi, je nedopustna in mora biti ustrezno sankcionirana. Uredništvo revije se je odločilo, da avtorji, vključno s soavtorji, ki so zlorabili zaupanje, ne morejo objavljati svojih prispevkov v naši reviji 3 leta. To je po oceni uredništva najmanjša možna kazen.
Pošiljanje prispevkov z istimi podatki, hipotezami,
acta medico-biotechnica
2019; 12 (2): 8-9
Ethical responsibility of journal editors and authors when publishing scientific publications
Ethics has been and always will be an important part of scientific research. Guidelines are not always followed, however, and we must, on the basis of experience, take care to ensure that science remains ethical. Indeed, ethics is a consideration that pertains to all areas of research. Unethical practices in the pursuit of success, fame, or personal benefit must be strictly controlled to prevent the possibility of misusing science. This is the wish and the mission of our editorship.
Why am I dealing with this theme in the editorial? The reason relates to a recent case of unethical authorship. Our journal came close to publishing a previously published article in which the authors made a contradictory statement. After ten years of publishing this journal, we simply did not believe we would encounter such a case of misuse, for we placed our trust in the integrity of the authors. That was our mistake, and unfortunately, we can no longer proceed with this level of trust. What is instead necessary is to control and sanction authors who attempt duplicate publication. In this recent case, we were lucky to discover the malfeasance in time. For that, we owe exclusive thanks to an excellent reviewer who exposed the matter and drew our attention to it. This underscores the exceptional importance of reviewers and their work to confirm the authenticity of research, especially in the field of medicine—a sensitive field, particularly with regard to ethics. Many journals insist that authors append a statement that confirms the authenticity of their research, explicitly declaring that the submission has not been sent for publication to other scientific journals. Our journal requires this as well. To proceed ethically, authors must wait to hear back from a journal
Uvodnik / Editorial
razpravljanjem imenujemo podvajanje publikacije (duplicate publication), kar je podobno kot plagia-torstvo. COPE klasifikacija uvršča dvojno publikacijo v velike in manjše zadeve. Velika motnja se šteje, kadar gre za iste podatke, z enakimi zaključki in avtorji, pri čemer gre lahko za spremembo v avtorstvu ali v predhodno objavljenem prispevku. Manjša motnja je označena kot »salami slicing« z znaki dvojnega objavljanja pri ponovni analizi ali ponavljanju, kjer gre za razširitev skupine ali nadgradnjo metod. Pogosto so za objavljanje zlorabljene revije, ki izhajajo v jeziku, ki ni angleški. Gre za izrazito neetično obnašanje avtorjev.
Na uredništvu je pomembna in odgovorna dolžnost se tega zavedati in ustrezno ukrepati. Vse tiste, ki se poslužujejo neetičnega pristopa k objavljanju prispevkov, moramo ustrezno sankcionirati in tako preprečiti zlorabo objavljanja.
Znanost je ena in edina, posledice njene zlorabe so strahotne; ne sodelujmo v teh dogodkih. Ustavimo zlorabo in prispevajmo k varni znanosti.
Red. prof. dr. Dušica Pahor, odgovorna urednica
Bonis nocet, qui malis parcit. (Seneka)
Dobrim škodi, kdor prizanaša zlim.
before submitting their paper to another. A violation of this standard is unacceptable and must be correspondingly sanctioned. The editorship of this journal has thus decided that authors, including co-authors, who abuse these rules—and, in turn, our trust—will be prohibited from publishing articles in our journal for a period of three years. According to the judgement of our editorship, this is the minimum sanction that must be imposed. Submitting articles with identical data, hypotheses, and discussion constitutes a case of duplicate publication, on par with plagiarism. The COPE classification divides duplicate publications into major or minor offences. A major offence is regarded as a case of identical data, with the same conclusions, even in cases where there is change in the authorship. A minor offence involves the attempt at so-called 'salami' publication—authors seeking to publish articles that exhibit characteristics of duplicate publications: renewed analysis or repetition, with group expansion or upgraded methods. Journals that are not issued in English are often misused in publishing. To do so represents a distinctive case of unethical author behaviour.
It is the duty of this editorship to be vigilant of these dangers and to take the appropriate measures. Any authors who adopt an unethical approach to publishing their work will henceforth be sanctioned in an effort to prevent attempts at fraudulent publications. Science is sacrosanct, and the consequences of its misuse are disastrous. We must not tolerate unethical scientific practices. Rather, we must work together to protect the principles of scientific research.
Full Professor Dušica Pahor, MD Editor-in-Chief
Bonis nocet, qui malis parcit. (Seneka)
He harms the good people who spares the evil.
acta medico-biotechnica
2019; 12 (2): 9-9